Clinical trial
Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma…
NCT00092092 · Organon and Co, Industry · Completed
Key facts
| NCT number | NCT00092092 |
|---|---|
| Title | Study of Montelukast and Its Effect on Lower Leg Growth in Children With Asthma (MK-0476-254) |
| Official title | A Double-Blind, Double-Dummy, Randomized, Placebo-Controlled, 2-Arm, 2X2 Crossover Study Comparing the Effects of Montelukast, Inhaled Budesonide, and Placebo on Lower Leg Growth in Children (Prepubertal, Tanner Stage I) With Mild Asthma |
| Lead sponsor | Organon and Co, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asthma, Bronchial |
| Intervention type | Drug |
| Interventions | Montelukast chewable tablets, Budesonide inhaler, Placebo to montelukast chewable tablets, Placebo to budesonide inhaler |
| Enrollment | 71 |
| Start date | Oct 1, 2002 |
| Primary completion | Jun 1, 2004 |
| Completion | Jun 1, 2004 |
| First posted | Sep 24, 2004 |
| Last update posted | Aug 14, 2024 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: